MedTrace Logo

The Genetics of Dilated Cardiomyopathy: A Quebec-Based Study

NCT00523653 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2008-03-19

No results posted yet for this study

Summary

Dilated cardiomyopathy (DCM) affects about 200,000 Canadians. Eighty percent of these cases are of unclear cause, often occuring in families. We believe that mutations in specific already-identified genes contribute to DCM in Quebec and that certain mutations may account for a significant proportion of cases due to the well-documented "founder effect". Two hundred patients with DCM followed in our Heart Function Clinic will be approached for one blood sample at their routine clinic visit to test this hypothesis. The samples will be tested in the Laboratory of Cardiovascular Genetics at the Royal Victoria Hospital.

Conditions

  • Dilated Cardiomyopathy (DCM)

Interventions

OTHER

blood test

looking at DNA

Sponsors & Collaborators

  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    lead OTHER

Principal Investigators

  • Nadia S Giannetti, MD · McGill University Hospital Centre

  • Jamie Engert, PhD · McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Completion
2008-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00523653 on ClinicalTrials.gov